DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Istodax (Romidepsin) - General Physical Health Deterioration - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with General Physical Health Deterioration (4)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Istodax (Romidepsin) where reactions include general physical health deterioration. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Istodax side effects in female

Reported by a physician from France on 2012-07-18

Patient: female, weighing 40.0 kg (88.0 pounds)

Reactions: Pneumonia, General Physical Health Deterioration, Febrile Neutropenia, Neutrophil Count Decreased

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Adriamycin PFS
    Indication: non-Hodgkin's Lymphoma
    Start date: 2011-10-27
    End date: 2012-04-13

Cyclophosphamide
    Indication: non-Hodgkin's Lymphoma
    Start date: 2011-10-27
    End date: 2012-04-13

Istodax
    Indication: non-Hodgkin's Lymphoma
    Start date: 2011-10-27
    End date: 2012-04-12

Prednisone
    Indication: non-Hodgkin's Lymphoma
    Start date: 2011-10-27
    End date: 2012-04-13

Vincristine
    Indication: non-Hodgkin's Lymphoma
    Start date: 2011-10-27
    End date: 2012-04-13



Possible Istodax side effects in female

Reported by a physician from France on 2012-06-27

Patient: female, weighing 40.0 kg (88.0 pounds)

Reactions: General Physical Health Deterioration, Febrile Neutropenia, Pyrexia, Neutrophil Count Decreased

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Adriamycin PFS
    Indication: non-Hodgkin's Lymphoma
    Start date: 2011-10-27
    End date: 2012-04-13

Cyclophosphamide
    Indication: non-Hodgkin's Lymphoma
    Start date: 2011-10-27
    End date: 2012-04-13

Istodax
    Dosage: 14 milligram
    Indication: non-Hodgkin's Lymphoma
    Start date: 2011-10-27
    End date: 2012-04-12

Prednisone TAB
    Indication: non-Hodgkin's Lymphoma
    Start date: 2011-10-27
    End date: 2012-04-13

Vincristine Sulfate
    Indication: non-Hodgkin's Lymphoma
    Start date: 2011-10-27
    End date: 2012-04-13



Possible Istodax side effects in female

Reported by a physician from France on 2012-05-29

Patient: female, weighing 40.0 kg (88.0 pounds)

Reactions: Febrile Neutropenia, General Physical Health Deterioration, Pyrexia, Neutrophil Count Decreased

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Adriamycin PFS
    Indication: non-Hodgkin's Lymphoma
    Start date: 2011-10-27
    End date: 2012-04-13

Cyclophosphamide
    Indication: non-Hodgkin's Lymphoma
    Start date: 2011-10-27
    End date: 2012-04-13

Istodax
    Dosage: 14 milligram
    Indication: non-Hodgkin's Lymphoma
    Start date: 2011-10-27
    End date: 2012-04-12

Prednisone TAB
    Indication: non-Hodgkin's Lymphoma
    Start date: 2011-10-27
    End date: 2012-04-13

Vincristine
    Indication: non-Hodgkin's Lymphoma
    Start date: 2011-10-27
    End date: 2012-04-13



Possible Istodax side effects in female

Reported by a physician from Italy on 2012-05-01

Patient: female

Reactions: Weight Decreased, Night Sweats, Product Contamination Microbial, Blood Lactate Dehydrogenase Increased, Drug Intolerance, Anaemia, Congestive Cardiomyopathy, General Physical Health Deterioration, Pyrexia, Death, Peripheral T-Cell Lymphoma Unspecified, Asthenia, Decreased Appetite

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Istodax
    Indication: Peripheral T-Cell Lymphoma Unspecified
    Start date: 2011-11-30
    End date: 2011-12-14

Istodax
    Start date: 2012-01-09

Other drugs received by patient: Corticosteroids

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017